Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls
Travis T. Sims(The University of Texas MD Anderson Cancer Center), Ann H. Klopp(The University of Texas MD Anderson Cancer Center), Andrea Y. Delgado Medrano(The University of Texas MD Anderson Cancer Center), Lauren E. Colbert(The University of Texas MD Anderson Cancer Center), Jiali Zheng(The University of Texas MD Anderson Cancer Center), Lois M. Ramondetta(The University of Texas MD Anderson Cancer Center), Carrie R. Daniel(The University of Texas MD Anderson Cancer Center), Kathleen M. Schmeler(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Kristi L. Hoffman(Baylor College of Medicine), Anuja Jhingran(The University of Texas MD Anderson Cancer Center)
Cited by 110
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
|The Lancet Oncology|2018|658
Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
|Stem Cells|2010|571
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508